Bluejay Diagnostics, Inc. Operating Expenses
Bluejay Diagnostics, Inc. (BJDX) reported Operating Expenses of $2.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-12
- Bluejay Diagnostics, Inc. operating expenses for the quarter ending 2026-06-30 was $2.35M, a 18.32% increase year-over-year.
- Bluejay Diagnostics, Inc. operating expenses for the quarter ending 2026-03-31 was $1.94M, a 2.64% increase year-over-year.
- Bluejay Diagnostics, Inc. operating expenses for the quarter ending 2025-12-31 was $1.46M, a 1.54% decline year-over-year.
- Bluejay Diagnostics, Inc. operating expenses for the quarter ending 2025-09-30 was $1.62M, a 18.75% increase year-over-year.
- Bluejay Diagnostics, Inc. operating expenses for fiscal 2025 was $6.95M, a 3.02% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. operating expenses for fiscal 2024 was $7.17M, a 30.47% decline from fiscal 2023.
- Bluejay Diagnostics, Inc. operating expenses for fiscal 2023 was $10.31M, a 10.08% increase from fiscal 2022.
- Bluejay Diagnostics, Inc. operating expenses for fiscal 2022 was $9.37M, a 189.98% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.35M 10-Q · filed 2026-08-12 | $4.29M 10-Q · filed 2026-08-12 | $5.75M derived: sum of 3 quarters · filed 2026-08-12 | $7.37M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $1.94M 10-Q · filed 2026-05-07 | $3.40M derived: sum of 2 quarters · filed 2026-05-07 | $5.02M derived: sum of 3 quarters · filed 2026-05-07 | $7.00M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $3.08M derived: sum of 2 quarters · filed 2026-03-06 | $5.06M derived: sum of 3 quarters · filed 2026-08-12 | $6.95M 10-K · filed 2026-03-06 |
| 2025-09-30 | $1.62M 10-Q · filed 2025-11-07 | $3.60M derived: sum of 2 quarters · filed 2026-08-12 | $5.49M 10-Q · filed 2025-11-07 | $6.98M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $1.99M 10-Q · filed 2026-08-12 | $3.87M 10-Q · filed 2026-08-12 | $5.36M derived: sum of 3 quarters · filed 2026-08-12 | $6.72M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.89M 10-Q · filed 2026-05-07 | $3.37M derived: sum of 2 quarters · filed 2026-05-07 | $4.74M derived: sum of 3 quarters · filed 2026-05-07 | $6.63M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.85M derived: sum of 2 quarters · filed 2026-03-06 | $4.74M derived: sum of 3 quarters · filed 2026-03-06 | $7.17M 10-K · filed 2026-03-06 |
| 2024-09-30 | $1.36M 10-Q · filed 2025-11-07 | $3.26M derived: sum of 2 quarters · filed 2025-11-07 | $5.68M 10-Q · filed 2025-11-07 | $8.07M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $1.90M 10-Q · filed 2025-08-07 | $4.32M 10-Q · filed 2025-08-07 | $6.71M derived: sum of 3 quarters · filed 2025-08-07 | $9.05M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $2.43M 10-Q · filed 2025-05-13 | $4.81M derived: sum of 2 quarters · filed 2025-05-13 | $7.16M derived: sum of 3 quarters · filed 2025-05-13 | $10.06M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.73M derived: sum of 2 quarters · filed 2025-03-31 | $7.63M derived: sum of 3 quarters · filed 2025-03-31 | $10.31M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.34M 10-Q · filed 2024-11-07 | $5.24M derived: sum of 2 quarters · filed 2024-11-07 | $7.92M 10-Q · filed 2024-11-07 | $10.38M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.90M 10-Q · filed 2024-08-14 | $5.58M 10-Q · filed 2024-08-14 | $8.04M derived: sum of 3 quarters · filed 2024-08-14 | $10.85M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $2.68M 10-Q · filed 2024-05-15 | $5.13M derived: sum of 2 quarters · filed 2024-05-15 | $7.94M derived: sum of 3 quarters · filed 2024-05-15 | $9.98M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $5.26M derived: sum of 2 quarters · filed 2024-03-28 | $7.30M derived: sum of 3 quarters · filed 2024-03-28 | $9.37M 10-K · filed 2024-03-28 |
| 2022-09-30 | $2.81M 10-Q · filed 2023-11-09 | $4.84M derived: sum of 2 quarters · filed 2023-11-09 | $6.91M 10-Q · filed 2023-11-09 | $8.29M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $2.03M 10-Q · filed 2023-08-14 | $4.10M 10-Q · filed 2023-08-14 | $5.48M derived: sum of 3 quarters · filed 2023-08-14 | $6.43M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.07M 10-Q · filed 2023-05-11 | $3.44M derived: sum of 2 quarters · filed 2023-05-11 | $4.40M derived: sum of 3 quarters · filed 2023-05-11 | $5.07M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $2.33M derived: sum of 2 quarters · filed 2023-03-20 | $3.00M derived: sum of 3 quarters · filed 2023-03-20 | $3.23M 10-K · filed 2023-03-20 |
| 2021-09-30 | $957.99K 10-Q · filed 2022-11-09 | $1.62M derived: sum of 2 quarters · filed 2022-11-09 | $1.86M 10-Q · filed 2022-11-09 | $2.44M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $666.07K 10-Q · filed 2022-08-10 | $899.27K 10-Q · filed 2022-08-10 | $1.48M derived: sum of 3 quarters · filed 2022-08-10 | $1.63M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $233.20K 10-Q · filed 2022-05-09 | $814.98K derived: sum of 2 quarters · filed 2022-05-09 | $963.15K derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $581.78K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $729.95K derived: sum of 2 quarters · filed 2022-03-10 | $1.20M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $148.17K 10-Q · filed 2021-12-16 | $614.61K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |